Ropes & Gray advised Pfizer on the deal. Pfizer announced its strategic investment in and collaboration with CellCentric, which includes $25 million to help finance further development...
Pfizer’s $25 Million Strategic Investment in CellCentric
Solarea Bio’s Series B Financing
Ropes & Gray represented Solarea Bio on the deal. Solarea Bio, a clinical stage biotechnology developing food-derived microbial-based solutions to aid human health, announced a first closing...